OPKO Health Gross Margin 2010-2024 | OPK
Current and historical gross margin for OPKO Health (OPK) over the last 10 years. The current gross profit margin for OPKO Health as of September 30, 2024 is %.
| OPKO Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.71B | $0.18B | 25.14% |
| 2024-06-30 | $0.72B | $0.19B | 26.08% |
| 2024-03-31 | $0.80B | $0.26B | 32.63% |
| 2023-12-31 | $0.86B | $0.32B | 36.81% |
| 2023-09-30 | $0.87B | $0.33B | 37.95% |
| 2023-06-30 | $0.87B | $0.31B | 35.94% |
| 2023-03-31 | $0.91B | $0.30B | 33.08% |
| 2022-12-31 | $1.00B | $0.29B | 28.69% |
| 2022-09-30 | $1.22B | $0.34B | 27.95% |
| 2022-06-30 | $1.43B | $0.45B | 31.70% |
| 2022-03-31 | $1.56B | $0.49B | 31.19% |
| 2021-12-31 | $1.77B | $0.58B | 32.86% |
| 2021-09-30 | $1.87B | $0.65B | 34.80% |
| 2021-06-30 | $1.91B | $0.66B | 34.71% |
| 2021-03-31 | $1.77B | $0.65B | 36.86% |
| 2020-12-31 | $1.44B | $0.54B | 37.70% |
| 2020-09-30 | $1.16B | $0.45B | 38.40% |
| 2020-06-30 | $0.97B | $0.38B | 39.27% |
| 2020-03-31 | $0.89B | $0.32B | 36.18% |
| 2019-12-31 | $0.90B | $0.33B | 36.51% |
| 2019-09-30 | $0.90B | $0.32B | 35.48% |
| 2019-06-30 | $0.92B | $0.33B | 35.98% |
| 2019-03-31 | $0.96B | $0.36B | 37.89% |
| 2018-12-31 | $0.99B | $0.39B | 38.95% |
| 2018-09-30 | $0.93B | $0.32B | 34.19% |
| 2018-06-30 | $0.93B | $0.31B | 33.91% |
| 2018-03-31 | $0.96B | $0.34B | 35.08% |
| 2017-12-31 | $0.97B | $0.35B | 35.82% |
| 2017-09-30 | $0.98B | $0.35B | 36.27% |
| 2017-06-30 | $1.03B | $0.41B | 39.49% |
| 2017-03-31 | $1.09B | $0.48B | 43.50% |
| 2016-12-31 | $1.12B | $0.51B | 45.39% |
| 2016-09-30 | $1.22B | $0.63B | 51.39% |
| 2016-06-30 | $1.07B | $0.56B | 52.20% |
| 2016-03-31 | $0.75B | $0.38B | 50.66% |
| 2015-12-31 | $0.49B | $0.26B | 52.34% |
| 2015-09-30 | $0.24B | $0.14B | 57.26% |
| 2015-06-30 | $0.12B | $0.07B | 60.17% |
| 2015-03-31 | $0.10B | $0.05B | 54.00% |
| 2014-12-31 | $0.09B | $0.04B | 47.83% |
| 2014-09-30 | $0.09B | $0.04B | 44.83% |
| 2014-06-30 | $0.09B | $0.04B | 44.32% |
| 2014-03-31 | $0.09B | $0.04B | 44.32% |
| 2013-12-31 | $0.10B | $0.05B | 50.52% |
| 2013-09-30 | $0.09B | $0.05B | 51.09% |
| 2013-06-30 | $0.08B | $0.04B | 50.60% |
| 2013-03-31 | $0.07B | $0.04B | 50.72% |
| 2012-12-31 | $0.05B | $0.02B | 40.43% |
| 2012-09-30 | $0.04B | $0.01B | 37.84% |
| 2012-06-30 | $0.03B | $0.01B | 40.63% |
| 2012-03-31 | $0.03B | $0.01B | 43.33% |
| 2011-12-31 | $0.03B | $0.01B | 42.86% |
| 2011-09-30 | $0.03B | $0.02B | 62.07% |
| 2011-06-30 | $0.03B | $0.02B | 60.71% |
| 2011-03-31 | $0.03B | $0.02B | 59.26% |
| 2010-12-31 | $0.03B | $0.02B | 53.57% |
| 2010-09-30 | $0.02B | $0.01B | 36.84% |
| 2010-06-30 | $0.02B | $0.01B | 33.33% |
| 2010-03-31 | $0.01B | $0.00B | 30.00% |
| 2009-12-31 | $0.00B | $0.00B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.106B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $194.739B | 23.76 |
| Intuitive Surgical (ISRG) | United States | $191.917B | 100.34 |
| Alcon (ALC) | Switzerland | $42.138B | 28.19 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $34.726B | 19.13 |
| IDEXX Laboratories (IDXX) | United States | $34.092B | 40.15 |
| DexCom (DXCM) | United States | $29.248B | 44.05 |
| STERIS (STE) | Ireland | $20.926B | 24.09 |
| Waters (WAT) | United States | $20.468B | 30.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $18.250B | 19.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.969B | 13.31 |
| Sysmex ADR (SSMXY) | Japan | $12.688B | 39.79 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.100B | 89.14 |
| Teleflex (TFX) | United States | $8.967B | 14.30 |
| Masimo (MASI) | United States | $8.754B | 42.36 |
| Glaukos (GKOS) | United States | $7.951B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.883B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.479B | 25.38 |
| Veracyte (VCYT) | United States | $3.034B | 91.05 |
| Inari Medical (NARI) | United States | $2.984B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.789B | 16.10 |
| TransMedics (TMDX) | United States | $2.783B | 88.21 |
| Nihon Kohden (NHNKY) | Japan | $2.293B | 17.42 |
| Elekta AB (EKTAY) | Sweden | $2.192B | 17.86 |
| Tandem Diabetes Care (TNDM) | United States | $1.830B | 0.00 |
| RxSight (RXST) | United States | $1.819B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.766B | 9.23 |
| Alphatec Holdings (ATEC) | United States | $1.357B | 0.00 |
| Artivion (AORT) | United States | $1.129B | 74.81 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| Paragon 28 (FNA) | United States | $0.879B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.818B | 13.91 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 35.10 |
| OrthoPediatrics (KIDS) | United States | $0.589B | 0.00 |
| AxoGen (AXGN) | United States | $0.561B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.542B | 12.77 |
| SiBone (SIBN) | United States | $0.517B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.483B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.471B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.48 |
| Semler Scientific (SMLR) | United States | $0.337B | 22.60 |
| CVRx (CVRX) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.317B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.274B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.161B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Nevro (NVRO) | United States | $0.159B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.137B | 14.68 |
| Spectral Diagnostics (EDTXF) | Canada | $0.112B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| 908 Devices (MASS) | United States | $0.086B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.078B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Neuronetics (STIM) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |